![John Berdahl](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Berdahl
Algemeen Directeur bij Equinox Ophthalmic, Inc.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
J. Corley | M | 68 |
Equinox Ophthalmic, Inc.
![]() Equinox Ophthalmic, Inc. Miscellaneous Commercial ServicesCommercial Services Equinox Ophthalmic, Inc. operates as a biotechnology company. It specializes in cataract, corneal and glaucoma surgery. The company was founded by John Berdahl and is headquartered in Sioux Falls, SD.
Melt Pharmaceuticals, Inc.
![]() Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | 5 jaar |
Matthew Larson | M | - |
Equinox Ophthalmic, Inc.
![]() Equinox Ophthalmic, Inc. Miscellaneous Commercial ServicesCommercial Services Equinox Ophthalmic, Inc. operates as a biotechnology company. It specializes in cataract, corneal and glaucoma surgery. The company was founded by John Berdahl and is headquartered in Sioux Falls, SD. | 7 jaar |
Larry Dillaha | M | 60 |
Melt Pharmaceuticals, Inc.
![]() Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | 3 jaar |
Arthur Laffer | M | 83 |
Melt Pharmaceuticals, Inc.
![]() Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | 2 jaar |
Mark Baum | M | 51 |
Melt Pharmaceuticals, Inc.
![]() Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | - |
Richard Lindstrom | M | 76 |
Equinox Ophthalmic, Inc.
![]() Equinox Ophthalmic, Inc. Miscellaneous Commercial ServicesCommercial Services Equinox Ophthalmic, Inc. operates as a biotechnology company. It specializes in cataract, corneal and glaucoma surgery. The company was founded by John Berdahl and is headquartered in Sioux Falls, SD. | - |
Bill Link | M | 78 |
Equinox Ophthalmic, Inc.
![]() Equinox Ophthalmic, Inc. Miscellaneous Commercial ServicesCommercial Services Equinox Ophthalmic, Inc. operates as a biotechnology company. It specializes in cataract, corneal and glaucoma surgery. The company was founded by John Berdahl and is headquartered in Sioux Falls, SD. | - |
Tyler Stowater | M | 61 |
Equinox Ophthalmic, Inc.
![]() Equinox Ophthalmic, Inc. Miscellaneous Commercial ServicesCommercial Services Equinox Ophthalmic, Inc. operates as a biotechnology company. It specializes in cataract, corneal and glaucoma surgery. The company was founded by John Berdahl and is headquartered in Sioux Falls, SD. | - |
Stuart Raetzman | M | 61 |
Equinox Ophthalmic, Inc.
![]() Equinox Ophthalmic, Inc. Miscellaneous Commercial ServicesCommercial Services Equinox Ophthalmic, Inc. operates as a biotechnology company. It specializes in cataract, corneal and glaucoma surgery. The company was founded by John Berdahl and is headquartered in Sioux Falls, SD. | 4 jaar |
Jeffry Weinhuff | M | - |
Equinox Ophthalmic, Inc.
![]() Equinox Ophthalmic, Inc. Miscellaneous Commercial ServicesCommercial Services Equinox Ophthalmic, Inc. operates as a biotechnology company. It specializes in cataract, corneal and glaucoma surgery. The company was founded by John Berdahl and is headquartered in Sioux Falls, SD. | - |
D. Osborne | M | 45 |
Melt Pharmaceuticals, Inc.
![]() Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | 2 jaar |
Giovanni de Castro | M | - |
Melt Pharmaceuticals, Inc.
![]() Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | 3 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 12 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- John Berdahl
- Persoonlijk netwerk